Liisa Palmer, PhD

home / authors / liisa-palmer-phd

Articles

Site Logo

Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease

David T. Rubin, MD;Sunanda Kane, MD;Srihari Jaganathan, MS;Liisa Palmer, PhD;Anissa Cyhaniuk, MA
October 27th 2015

This study evaluated the rates of dose escalation in patients with Crohn's disease.

Read More

Site Logo

Impact of Patient Cost Sharing on Multiple Sclerosis Treatment

Liisa Palmer, PhD;Safiya Abouzaid, PharmD;Nianwen Shi, PhD;Robert Fowler, MS;Greg Lenhart, MS;Homa Dastani, PhD;Edward Kim, MD, MBA
November 14th 2012

This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD